Weihai Baihe Biotechnology Co., Ltd
Announcement of IPO results
Sponsor (lead underwriter): Gf Securities Co.Ltd(000776)
hot tip
The application of Weihai Baihe Biotechnology Co., Ltd. (hereinafter referred to as “Baihe shares”, “issuer” or “company”) for the initial public offering of no more than 16 million RMB common shares (A shares) (hereinafter referred to as “this offering”) has been approved by CSRC permit (2022) No. 36, The sponsor (lead underwriter) of this offering is Gf Securities Co.Ltd(000776) (hereinafter referred to as ” Gf Securities Co.Ltd(000776) ” or “sponsor (lead underwriter)”). The issuer’s shares are referred to as “lily shares” for short, and the stock code is “603102”.
This issuance adopts the direct pricing method, and all shares are issued online to the social public investors holding a certain market value of non restricted A-Shares and non restricted depositary receipts in Shanghai market (hereinafter referred to as “online issuance”), without offline inquiry and placement. The issuer and the sponsor (lead underwriter) comprehensively considered the issuer’s fundamentals, the valuation level of comparable companies, the industry, market conditions, the demand for raised funds, underwriting risks and other factors, and negotiated and determined that the issuance price of the shares was 42.14 yuan / share, and the number of shares issued was 16 million, all of which were new shares without the transfer of old shares. In this offering, 16 million shares were issued online, accounting for 100% of the total.
The online subscription and payment of this offering has been completed on January 18, 2022 (T + 2).
1、 Statistics on subscription of new shares
According to the data provided by Shanghai Stock Exchange and China Securities Depository and Clearing Co., Ltd. Shanghai Branch (hereinafter referred to as “CSDCC Shanghai Branch”), the sponsor (lead underwriter) has made statistics on the subscription of new shares issued online. The results are as follows:
1. Number of shares subscribed by online investors: 15862174 shares
2. Subscription amount paid by online investors: 668432012.36 yuan
3. Number of online investors giving up subscription: 137826 shares
4. Subscription amount abandoned by online investors: 5807987.64 yuan II. Underwriting by sponsor (lead underwriter)
All the shares abandoned by online investors are underwritten by the sponsor (lead underwriter). The number of shares that online investors give up subscription is 137826, and the number of shares underwritten by the sponsor (lead underwriter) is 137826, with an underwriting amount of 5807987.64 yuan and an underwriting proportion of 0.86%.
On January 20, 2022 (T + 4), the sponsor (lead underwriter) transferred the underwriting funds and the funds paid and subscribed by online investors to the issuer after deducting relevant expenses. The issuer submitted an application for share registration to China Clearing Shanghai branch and registered the underwriting shares to the securities account designated by the sponsor (lead underwriter). 3、 Contact information of sponsor (lead underwriter)
If online investors have any questions about the issuance results announced in this announcement, please contact the sponsor (lead underwriter) of this issuance. Contact details are as follows:
Tel: 020-66338151, 66338152
Contact: capital market department
Issuer: sponsor (lead underwriter) of Weihai Lily Biotechnology Co., Ltd.: Gf Securities Co.Ltd(000776) January 20, 2022
